| Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry I Rodríguez-Pintó, M Moitinho, I Santacreu, Y Shoenfeld, D Erkan, ... Autoimmunity Reviews 15 (12), 1120-1124, 2016 | 304 | 2016 |
| Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab H Berman, I Rodríguez-Pintó, R Cervera, N Morel, ... Autoimmunity Reviews 12 (11), 1085-1090, 2013 | 267 | 2013 |
| 14th international congress on antiphospholipid antibodies task force report on catastrophic antiphospholipid syndrome R Cervera, I Rodríguez-Pintó, S Colafrancesco, F Conti, G Valesini, ... Autoimmunity Reviews 13 (7), 699-707, 2014 | 238 | 2014 |
| Fibromyalgia and cytokines I Rodriguez-Pintó, N Agmon-Levin, A Howard, Y Shoenfeld Immunology letters 161 (2), 200-203, 2014 | 237 | 2014 |
| The diagnosis and clinical management of the catastrophic antiphospholipid syndrome: a comprehensive review R Cervera, I Rodríguez-Pintó, G Espinosa Journal of autoimmunity 92, 1-11, 2018 | 212 | 2018 |
| McMaster RARE‐Bestpractices clinical practice guideline on diagnosis and management of the catastrophic antiphospholipid syndrome K Legault, H Schunemann, C Hillis, C Yeung, EA Akl, M Carrier, ... Journal of Thrombosis and Haemostasis 16 (8), 1656-1664, 2018 | 152 | 2018 |
| Integrative analysis reveals a molecular stratification of systemic autoimmune diseases G Barturen, S Babaei, F Català‐Moll, M Martínez‐Bueno, Z Makowska, ... Arthritis & rheumatology 73 (6), 1073-1085, 2021 | 144 | 2021 |
| A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome P Soret, C Le Dantec, E Desvaux, N Foulquier, B Chassagnol, S Hubert, ... Nature communications 12 (1), 3523, 2021 | 126 | 2021 |
| The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort M Radin, S Sciascia, D Erkan, V Pengo, MG Tektonidou, A Ugarte, ... Seminars in arthritis and rheumatism 49 (3), 464-468, 2019 | 113 | 2019 |
| The effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients I Rodríguez-Pintó, G Espinosa, D Erkan, Y Shoenfeld, R Cervera Rheumatology 57 (7), 1264-1270, 2018 | 105 | 2018 |
| Pediatric catastrophic antiphospholipid syndrome: descriptive analysis of 45 patients from the “CAPS Registry” H Berman, I Rodríguez-Pintó, R Cervera, S Gregory, E de Meis, ... Autoimmunity Reviews 13 (2), 157-162, 2014 | 91 | 2014 |
| Peripheral nervous system involvement in systemic lupus erythematosus: prevalence, clinical and immunological characteristics, treatment and outcome of a large cohort from a … P Toledano, R Orueta, I Rodríguez-Pintó, J Valls-Solé, R Cervera, ... Autoimmunity Reviews 16 (7), 750-755, 2017 | 74 | 2017 |
| Catastrophic APS in the context of other thrombotic microangiopathies I Rodríguez-Pintó, G Espinosa, R Cervera Current rheumatology reports 17, 1-10, 2015 | 69 | 2015 |
| Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study O Amengual, R Forastiero, M Sugiura-Ogasawara, K Otomo, K Oku, ... Lupus 26 (3), 266-276, 2017 | 68 | 2017 |
| Catastrophic antiphospholipid syndrome: The current management approach I Rodriguez-Pintó, G Espinosa, R Cervera Best practice & research clinical rheumatology 30 (2), 239-249, 2016 | 65 | 2016 |
| Eculizumab use in catastrophic antiphospholipid syndrome (CAPS): Descriptive analysis from the “CAPS Registry” B López-Benjume, I Rodríguez-Pintó, MC Amigo, D Erkan, Y Shoenfeld, ... Autoimmunity reviews 21 (4), 103055, 2022 | 61 | 2022 |
| “Non-criteria” antiphospholipid syndrome: a nomenclature proposal GP da Rosa, P Bettencourt, I Rodríguez-Pintó, R Cervera, G Espinosa Autoimmunity reviews 19 (12), 102689, 2020 | 60 | 2020 |
| Catastrophic antiphospholipid syndrome: task force report summary R Cervera, I Rodríguez-Pintó, ... Lupus 23 (12), 1283-1285, 2014 | 59 | 2014 |
| Development and validation of a risk calculator to differentiate flares from infections in systemic lupus erythematosus patients with fever S Beça, I Rodríguez-Pintó, MA Alba, R Cervera, G Espinosa Autoimmunity Reviews 14 (7), 586-593, 2015 | 48 | 2015 |
| Catastrophic antiphospholipid syndrome: an update. G Espinosa, I Rodríguez-Pintó, R Cervera Panminerva Medica 59 (3), 254-268, 2017 | 46 | 2017 |
Yehuda ShoenfeldСанкт-Петербургский государственный университетПідтверджена електронна адреса в spbu.ru